Lysergic Acid Diethylamide: Effect on Embryos
Robert Auerbach, James A. Rugowski
Science September 15, 1967 DOI: 10.1126/science.157.3794.1325 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study Peer reviewed |
|---|---|
| Population | Mice in early pregnancy |
| Topics | LSD |
| Keywords | Embryo Cell biology Biochemistry Receptor |
| Citations | 96 |
| Key findings | Injection of lysergic acid diethylamide tartrate into mice in early pregnancy caused a 57 percent incidence of grossly abnormal embryos. |
Abstract
Injection of lysergic acid diethylamide tartrate into mice in early pregnancy caused a 57 percent incidence of grossly abnormal embryos.
Comparable studies
Other preclinical and animal studies on LSD, most cited first.
Citations in the library
Cited by 18
- The Pharmacology of Lysergic Acid Diethylamide: A Review CNS Neuroscience & Therapeutics November 11, 2008
- Clinical applications of hallucinogens: A review. Experimental and Clinical Psychopharmacology August 1, 2016
- In Vivo and in Vitro Chromosomal Damage Induced by LSD-25 New England Journal of Medicine November 16, 1967
- LSD and Genetic Damage Science April 30, 1971
- Lysergic Acid Diethylamide New England Journal of Medicine February 22, 1968
and 13 more in the library
Cites 4
- Chromosomal Damage in Human Leukocytes Induced by Lysergic Acid Diethylamide Science March 17, 1967
- THE DISTRIBUTION AND METABOLISM OF LYSERGIC ACID DIETHYLAMIDE Annals of the New York Academy of Sciences March 1, 1957
- Chromosomal Abnormalities in Leukocytes from LSD-25 Users Science July 21, 1967
- D‐Lysergic acid diethylamide (LSD): A review of its present status Clinical Pharmacology & Therapeutics March 1, 1965